Sexually transmitted disease
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- A Disease due to or propagated by sexual contact.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Sexually transmitted disease
- Therapeutic area
- Infectious Disease
- sexually transmitted disease
- STD
- VD
- VD, venereal disease
- disease (VD), venereal
- sexually Transmitted disorder
- sexually transmitted disease
- venereal disease (VD)
- STDs
- STI
- STIs
- Transmitted infection, sexually
- Transmitted infections, sexually
- disease, sexually Transmitted
- disease, venereal
- diseases, sexually Transmitted
- diseases, venereal
- infection, sexually Transmitted
- infections, sexually Transmitted
- sexually Transmitted infection
- sexually Transmitted infections
- venereal disease
- venereal diseases
- Disease mechanisms
- Acquired
- Severity
- Unknown
- Infectious Disease
- Reproductive Health
- MONDO ID
- MONDO:0021681
- Parent condition
- MONDO:0005039
Related records
Broader conditions (7)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
- Reproductive system disorder
Narrower conditions (81)
- Acute gonococcal cervicitis
- Acute gonococcal cystitis
- Acute gonococcal epididymo-orchitis
- Acute gonococcal prostatitis
- Acute gonococcal salpingitis
- AIDS
- AIDS related complex
- Anal verrucous carcinoma
- Anogenital human papillomavirus infection
- Asymptomatic neurosyphilis
- Bacterial sexually transmitted disease
- Bejel
- Buschke Lowenstein tumor
- Cardiovascular syphilis
- Central nervous system AIDS arteritis
- Chancre
- Chancroid
- Chlamydia infectious disease
- Chlamydia trachomatis infectious disease
- Chronic gonococcal salpingitis
Trials (547)
- 'HI-4-TU' Study: Health Improvement for Teen Ugandans Study
- "Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
- #TranscendentHealth: A Text Messaging Pregnancy Prevention Program for Transgender Boys
- 500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection
- 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides
- A Case Control Study of Women With Multiple Sexual Partners
- A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
- A Cognitive Behavioral And Structural HIV Prevention Intervention for Young Ugandan Sex Workers
- A Community-Based Intervention With Popular Opinion Leaders (C-POL) in Texas
- A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women
- A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA
- A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
- A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Study
- A Healthcare Economic Study of the Click Sexual Health Test
- A Healthy Relationships Program for Vulnerable Youth
- A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China
- A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV
- A One-year Trajectory of Depression Status Changes in Older Adults With MCI and SD: a Longitudinal Cohort Study
- A Parent Child Program to Prevent Adolescent Pregnancy
- A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
Drugs in development (2)
- Nitazoxanide Phase 2
- Pentoxifylline Phase 2